Head & Neck· 2020Q1
Objective evaluation of anosmia and ageusia in <scp>COVID</scp>‐19 patients: Single‐center experience on 72 cases
- 461citations
- Q1SCImago
- 2020year
Short summary
In a single-center study of 72 COVID-19 patients, 73.6% reported chemosensitive disorders, with objective testing revealing hyposmia in 60 and anosmia in 2, and hypogeusia in 33 and ageusia in 1.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Sensory Systems
Sensory SystemsNeuroscience